Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

$Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow$
AI-based CAD assessments dramatically improve vascular surgery outcomes
PAD patients evaluated with HeartFlow's noninvasive FFR_CTAnalysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years.
FDA announces new recall of delivery catheters after patient’s death
The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.
Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE
The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.
TAVR linked to lower stroke risk than SAVR in patients with AS and cardiogenic shock
TAVR is also associated with a lower risk of acute kidney injury in this patient population. In-hospital mortality rates, however, are similar between the two treatment options.
PAD patients face greater risk of death, complications after a heart attack
PAD and CLI patients who show signs of coronary heart disease may benefit from early treatment, according to a new study of nearly 4 million hospitalizations.

IN.PACT Admiral Drug-Coated Balloon Cost-Effectiveness Study and Global Study Results of In-Stent Restenosis Population Highlighted in Late Breaking Clinical Trials at VIVA 2015

Medtronic plc (NYSE: MDT) adds to the robust data for its IN.PACT® Admiral® drug-coated balloon (DCB) with the presentation of both its formal cost-effectiveness analysis from the U.S. cohort of the IN.PACT SFA Trial and clinical results from the in-stent restenosis cohort data from Medtronic's IN.PACT Global Study.

November 3, 2015

Medtronic Unveils New Aortic and Peripheral Data from Two Late-Breaking Clinical Trials at VIVA 2015

Medtronic plc (NYSE: MDT) today announced new clinical data in interventional treatments for aortic and peripheral vascular diseases in a late-breaking trial session at Vascular Interventional Advances (VIVA) 2015.

November 3, 2015

Researchers identify molecule that may help patients recover after strokes

Researchers discovered a molecule that may be a potential therapy for patients recovering from a stroke. The molecule, known as growth and differentiation factor 10 (GDF10), is activated early after stroke, according to researchers from the department of neurology at the University of California, Los Angeles.

October 30, 2015

Stent retrievers make Cleveland Clinic’s top 10 medical innovations for 2016

As part of its annual Medical Innovation Summit, the Cleveland Clinic released its top 10 medical innovations for 2016. The list of the technologies that will have the biggest impact in healthcare included neurovascular stent retrievers, which are used after patients suffer an ischemic stroke.

October 30, 2015

Cook Medical expands voluntary recall of angiographic catheters

Cook Medical announced that it has expanded its voluntary recall of angiographic catheters to include all lots of specific sizes. 

October 15, 2015

TCT.15: Drug-coated balloon is superior to PTA in patients with peripheral artery disease

After two years of follow up, patients with peripheral artery disease who received a drug-coated balloon had significantly higher primary patency and a significantly lower rate of clinically driven target lesion revascularization compared with patients who received conventional percutaneous transluminal angioplasty (PTA).

October 15, 2015

Stroke, endovascular. neuroimaging, neuro

TCT.15: Stent retriever endovascular therapy improves clinical outcomes versus standard stroke therapy

A meta-analysis of five randomized controlled trials found that performing endovascular therapy with stent retrievers was safe and effective in managing acute ischemic stroke and led to a significant improvement in functional clinical outcomes compared with standard therapy.

October 12, 2015

FDA approves combination drug to treat pulmonary arterial hypertension

The FDA approved the combination of ambrisentan and tadalafil to reduce the risks of disease progression and hospitalization for worsening pulmonary arterial hypertension (PAH) and improve exercise ability.

October 8, 2015

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Vascular & Endovascular

AI-based CAD assessments dramatically improve vascular surgery outcomes

FDA announces new recall of delivery catheters after patient’s death

Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE

TAVR linked to lower stroke risk than SAVR in patients with AS and cardiogenic shock

PAD patients face greater risk of death, complications after a heart attack

Around the web